• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Reviewers
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Benha Medical Journal
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 39 (2022)
Issue Issue 1
Issue Special issue (Ophthalmology)
Volume Volume 38 (2021)
Volume Volume 37 (2020)
Volume Volume 36 (2019)
Abdel-Monem, S., Soliman, A., Marei, M., Elwia, S., Fawzy, R. (2022). Serum COLL2-1 In Rheumatoid Arthritis: Its Relation to Disease Activity and Severity. Benha Medical Journal, 39(1), 235-246. doi: 10.21608/bmfj.2021.90025.1456
Samia Mohamed Abdel-Monem; Amal Fathy Soliman; Mohammed Moustafa Marei; Sania Khairy Elwia; Rasha Mohamed Fawzy. "Serum COLL2-1 In Rheumatoid Arthritis: Its Relation to Disease Activity and Severity". Benha Medical Journal, 39, 1, 2022, 235-246. doi: 10.21608/bmfj.2021.90025.1456
Abdel-Monem, S., Soliman, A., Marei, M., Elwia, S., Fawzy, R. (2022). 'Serum COLL2-1 In Rheumatoid Arthritis: Its Relation to Disease Activity and Severity', Benha Medical Journal, 39(1), pp. 235-246. doi: 10.21608/bmfj.2021.90025.1456
Abdel-Monem, S., Soliman, A., Marei, M., Elwia, S., Fawzy, R. Serum COLL2-1 In Rheumatoid Arthritis: Its Relation to Disease Activity and Severity. Benha Medical Journal, 2022; 39(1): 235-246. doi: 10.21608/bmfj.2021.90025.1456

Serum COLL2-1 In Rheumatoid Arthritis: Its Relation to Disease Activity and Severity

Article 17, Volume 39, Issue 1, March and April 2022, Page 235-246  XML PDF (603.36 K)
Document Type: Original Article
DOI: 10.21608/bmfj.2021.90025.1456
Authors
Samia Mohamed Abdel-Monem1; Amal Fathy Soliman2; Mohammed Moustafa Marei email 3; Sania Khairy Elwia4; Rasha Mohamed Fawzy5
1Department of Rheumatology @ Rehabilitation- Faculty of Medicine- Benha University
2Department of Rheumatology, Rehabilitation and Physical Medicine, Faculty of Medicine, Benha University, Egypt.
3Department of Rheumatology, Rehabilitation and Physical Medicine, Faculty of Medicine, Banha University, Egypt.
4Department of Biochemistry, Faculty of Medicine, Banha University, Egypt.
5Rheumatology, Rehabilitation & physical Medicine / Faculty of Medicine / Benha University / Benha / Egypt
Abstract
Abstract:
Background: Rheumatoid arthritis is a chronic inflammatory disease characterized by proliferation of immunocompetent cells within synovial membranes. Type II collagen is the main protein component and specific for hyaline cartilage.
Aim: This work aimed to measure serum level of Coll2-1, in RA patients ,study its association with disease activity and/or severity, and to determine its ability as a biomarker of the disease status.
Patients and methods: This study was conducted on: Forty rheumatoid arthritis patients together with twenty primary knee OA patients and twenty volunteers as control groups. For RA patients; full history was obtained then clinical examination was performed. Disease activity. was assessed by DAS-28 and disease severity by Rheumatoid Arthritis Severity Scale (RASS). X- rays of both hands and feet graded by the Larsen score. Routine laboratory tests and serum Coll2-1 level was measured by ELISA.
Results: Statistically significant increase in the mean serum Coll2-1 levels among RA and OA patients compared to the healthy controls (p= 0.001 each). No difference was found between RA and OA (p=0.14). Significant positive correlations (p < 0.05) between serum level of Coll2-1 in RA patients with patients’ ages, morning stiffness duration, tender and swollen joints number , ESR, CRP, DAS-28, radiological grading and RASS. Conclusion: This study highlighted the importance of Coll 2-1 biomarker reflecting disease activity and the destructive processes emerging in the joints of RA patients. It could be a promising tool in the pathogenesis of significant joint activity signaling cartilage and joint destruction.
Key words: Coll2-1, Rheumatoid arthritis, Biomarkers.
Keywords
Coll2-1; Rheumatoid arthritis; Biomarkers
Statistics
Article View: 34
PDF Download: 26
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.